Two Sigma Securities’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,300
Closed -$122K 3117
2024
Q3
$122K Sell
13,300
-45,800
-77% -$379K ﹤0.01% 2246
2024
Q2
$578K Sell
59,100
-8,900
-13% -$109K 0.01% 1426
2024
Q1
$1.03M Buy
68,000
+51,000
+300% +$926K 0.01% 1124
2023
Q4
$366K Sell
17,000
-18,900
-53% -$349K ﹤0.01% 1816
2023
Q3
$667K Sell
35,900
-76,700
-68% -$1.79M 0.01% 1310
2023
Q2
$2.85M Buy
112,600
+78,800
+233% +$1.98M 0.04% 459
2023
Q1
$875K Sell
33,800
-84,000
-71% -$2.25M 0.02% 899
2022
Q4
$2.79M Buy
117,800
+2,000
+2% +$53.9K 0.08% 306
2022
Q3
$2.94M Buy
115,800
+62,000
+115% +$2.18M 0.09% 274
2022
Q2
$1.79M Buy
53,800
+33,300
+162% +$1.41M 0.06% 338
2022
Q1
$1.48M Buy
+20,500
New +$1.48M 0.05% 449
2021
Q4
Sell
-13,800
Closed -$1.75M 2028
2021
Q3
$1.75M Buy
13,800
+3,600
+35% +$524K 0.05% 318
2021
Q2
$1.7M Buy
+10,200
New +$1.65M 0.05% 273
2021
Q1
Sell
-1,500
Closed -$300K 1691
2020
Q4
$300K Buy
+1,500
New +$305K 0.01% 1050

Other funds holding TDOC

Two Sigma Securities's TDOC Position: Q2 2025 in Review

Two Sigma Securities sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 12,790 shares — an estimated $102K sold.

Two Sigma Securities first reported a position in TDOC in Q4 2018 and held it in 12 quarters. The position peaked at $1.26M in Q1 2022. 358 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • Two Sigma Securities reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 12,790 Teladoc Health shares in Q2 2025, an estimated $102K.
  • Two Sigma Securities first reported a position in Teladoc Health in Q4 2018 and held it in 12 quarters.
  • Two Sigma Securities's Teladoc Health position peaked at $1.26M in Q1 2022.
  • 358 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.